Article
Highly efficient vaccines for Bluetongue virus and a related Orbivirus based on reverse genetics
28 Jun 2020
Abstract excerpt
Bluetongue virus (BTV) reverse genetics (RG), available since 2007, has allowed the dissection of the virus replication cycle, including discovery of a primary replication stage. This information has allowed the generation of Entry-Competent-Replication-Abortive (ECRA) vaccines, which enter cells and complete primary replication but fail to complete the later stage. A series of vaccine trials in sheep and cattle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
